×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VYGR – voyager therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VYGR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/27
04:31 pm
vygr
Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease
Neutral
Report
Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease
4/17
06:02 am
vygr
Voyager Therapeutics (VYGR) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Medium
Report
Voyager Therapeutics (VYGR) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
3/26
05:49 am
vygr
Voyager Therapeutics (VYGR) was upgraded by Truist Financial Corporation to "strong-buy".
Low
Report
Voyager Therapeutics (VYGR) was upgraded by Truist Financial Corporation to "strong-buy".
3/23
02:13 am
vygr
Voyager Therapeutics, Inc. (VYGR) Presents at Stifel 2026 Virtual CNS Forum Transcript [Seeking Alpha]
Low
Report
Voyager Therapeutics, Inc. (VYGR) Presents at Stifel 2026 Virtual CNS Forum Transcript [Seeking Alpha]
3/22
11:27 pm
vygr
Voyager Therapeutics Conference: CEO Calls 2026 “Year of Tau,” Eyes BBB Capsid Clinic Debut [Yahoo! Finance]
Low
Report
Voyager Therapeutics Conference: CEO Calls 2026 “Year of Tau,” Eyes BBB Capsid Clinic Debut [Yahoo! Finance]
3/17
02:23 pm
vygr
Voyager Therapeutics (VYGR) had its "buy" rating reaffirmed by HC Wainwright. They now have a $25.00 price target on the stock.
Low
Report
Voyager Therapeutics (VYGR) had its "buy" rating reaffirmed by HC Wainwright. They now have a $25.00 price target on the stock.
3/14
01:32 am
vygr
Voyager Therapeutics (VYGR) was upgraded by Wall Street Zen from "sel
Medium
Report
Voyager Therapeutics (VYGR) was upgraded by Wall Street Zen from "sel
3/12
10:04 pm
vygr
Does Voyager Therapeutics' (VYGR) Widening Annual Loss Redefine the Risk-Reward in Its Neurology Pipeline? [Yahoo! Finance]
High
Report
Does Voyager Therapeutics' (VYGR) Widening Annual Loss Redefine the Risk-Reward in Its Neurology Pipeline? [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
3/9/2026
04:01 pm
VYGR
voyager therapeutics, inc.
BEAT
Report
21.7%
voyager therapeutics, inc.
11/10/2025
08:01 am
VYGR
voyager therapeutics, inc.
BEAT
Report
-3.4%
voyager therapeutics, inc.
8/6/2025
04:01 pm
VYGR
voyager therapeutics, inc.
MISS
Report
-4.5%
voyager therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/21
04:06 pm
vygr
Form 8-K Voyager Therapeutics, For: Apr 15
Low
Report
Form 8-K Voyager Therapeutics, For: Apr 15
4/10
04:22 pm
vygr
Form PRE 14A Voyager Therapeutics, For: Jun 09
Low
Report
Form PRE 14A Voyager Therapeutics, For: Jun 09
4/3
05:55 pm
vygr
Form 4 Voyager Therapeutics, For: Apr 02 Filed by: Sandrock Alfred
Medium
Report
Form 4 Voyager Therapeutics, For: Apr 02 Filed by: Sandrock Alfred
4/3
05:43 pm
vygr
Form 4 Voyager Therapeutics, For: Apr 01 Filed by: Shiferman Gregory L.
Medium
Report
Form 4 Voyager Therapeutics, For: Apr 01 Filed by: Shiferman Gregory L.
4/2
03:53 pm
vygr
Form 144 Voyager Therapeutics, Filed by: Sandrock Alfred
Low
Report
Form 144 Voyager Therapeutics, Filed by: Sandrock Alfred
3/27
02:17 pm
vygr
Form SCHEDULE 13G/A Voyager Therapeutics, Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Voyager Therapeutics, Filed by: VANGUARD GROUP INC
3/9
04:04 pm
vygr
Form 8-K Voyager Therapeutics, For: Mar 09
High
Report
Form 8-K Voyager Therapeutics, For: Mar 09
3/9
04:02 pm
vygr
Form 10-K Voyager Therapeutics, For: Dec 31
High
Report
Form 10-K Voyager Therapeutics, For: Dec 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
6/17
Form 8-K Voyager Therapeutics, For: Jun 14
14.3%
3/3 Q4/2019 12/31/2019 EPS -0.340 ZacksConsensus -0.660 ActVsEst 0.320 - Beat 9.8%
12/3 Form EFFECT Voyager Therapeutics, 8.5%
2/5 Voyager Therapeutics Inc (NASDAQ: VYGR) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.7%
2/6 Form SC 13G/A Voyager Therapeutics, Filed by: BlackRock Inc. 7.6%
4/7 Form 4 Voyager Therapeutics, For: Apr 03 Filed by: Hesslein Robert W. 7.4%
5/5 Neurocrine Biosciences and Voyager Therapeutics Announce Phase I Results for VY-AADC in Patients with Parkinson’s Disease at the American Academy of Neurology Annual Meeting 5.9%
5/20 Voyager Therapeutics Announces Management Updates 5.3%
3/19 Form 8-K Voyager Therapeutics, For: Mar 16 5.3%
3/30 Voyager Therapeutics Inc (NASDAQ: VYGR) had its price target lowered by analysts at Nomura from $37.00 to $16.00. They now have a "buy" rating on the stock. 4.9%
3/3 Q4/2019 12/31/2019 EPS -0.340 ZacksConsensus -0.660 ActVsEst 0.320 - Beat 9.8%
12/3 Form EFFECT Voyager Therapeutics, 8.5%
2/5 Voyager Therapeutics Inc (NASDAQ: VYGR) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.7%
2/6 Form SC 13G/A Voyager Therapeutics, Filed by: BlackRock Inc. 7.6%
4/7 Form 4 Voyager Therapeutics, For: Apr 03 Filed by: Hesslein Robert W. 7.4%
5/5 Neurocrine Biosciences and Voyager Therapeutics Announce Phase I Results for VY-AADC in Patients with Parkinson’s Disease at the American Academy of Neurology Annual Meeting 5.9%
5/20 Voyager Therapeutics Announces Management Updates 5.3%
3/19 Form 8-K Voyager Therapeutics, For: Mar 16 5.3%
3/30 Voyager Therapeutics Inc (NASDAQ: VYGR) had its price target lowered by analysts at Nomura from $37.00 to $16.00. They now have a "buy" rating on the stock. 4.9%
TOP News Decliners
11/6
Voyager Therapeutics Announces Third Quarter 2019 Financial Results and Corporate Highlights
-9.1%
2/25 Voyager Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates on March 3, 2020 -7.6%
8/9 Form 10-Q Voyager Therapeutics, For: Jun 30 -6.7%
4/3 Voyager Therapeutics Provides Update on the RESTORE-1 Parkinson’s Disease Trial -6.6%
1/17 Voyager Therapeutics Inc (NASDAQ: VYGR) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -5.9%
11/9 Voyager Therapeutics Inc (NASDAQ: VYGR) had its "outperform" rating re-affirmed by analysts at Wedbush. -5.9%
8/27 Voyager Therapeutics Inc (NASDAQ: VYGR) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -5.9%
3/5 Form SC 13G Voyager Therapeutics, Filed by: ARMISTICE CAPITAL, LLC -5.8%
3/17 Voyager Therapeutics Inc (NASDAQ: VYGR) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -4.3%
2/26 Voyager Therapeutics to Participate in Upcoming Investor Conferences -3.9%
2/25 Voyager Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates on March 3, 2020 -7.6%
8/9 Form 10-Q Voyager Therapeutics, For: Jun 30 -6.7%
4/3 Voyager Therapeutics Provides Update on the RESTORE-1 Parkinson’s Disease Trial -6.6%
1/17 Voyager Therapeutics Inc (NASDAQ: VYGR) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -5.9%
11/9 Voyager Therapeutics Inc (NASDAQ: VYGR) had its "outperform" rating re-affirmed by analysts at Wedbush. -5.9%
8/27 Voyager Therapeutics Inc (NASDAQ: VYGR) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -5.9%
3/5 Form SC 13G Voyager Therapeutics, Filed by: ARMISTICE CAPITAL, LLC -5.8%
3/17 Voyager Therapeutics Inc (NASDAQ: VYGR) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -4.3%
2/26 Voyager Therapeutics to Participate in Upcoming Investor Conferences -3.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: